Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Mittal

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancer Immunology Research|October 27, 2017
Interleukin-12 from CD103<sup>+</sup> Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of MetastasisDeepak Mittal, Dipti Vijayan, Eva M Putz, et al.
Touchreviews in Endocrinology|December 4, 2023
Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case ReportHiya Boro, Harish Sharma, Deepak Mittal, et al.
Touchreviews in Endocrinology|May 30, 2024
Erratum to Correct Informed Patient Consent StatementHiya Boro, Harish Sharma, Deepak Mittal, et al.
Cancer Research|September 1, 2017
CD73 Promotes Resistance to HER2/ErbB2 Antibody TherapyMartin Turcotte, David Allard, Deepak Mittal, et al.
Immunology and Cell Biology|September 18, 2018
The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cellsAilin Lepletier, Viviana P Lutzky, Deepak Mittal, et al.
Oncoimmunology|June 15, 2018
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisHeidi Harjunpää, Stephen J Blake, Elizabeth Ahern, et al.
Frontiers in Immunology|April 5, 2018
Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt SignalingJessica C Kling, Margaret A Jordan, Lauren A Pitt, et al.
EMBO Molecular Medicine|August 16, 2018
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerMurugan Kalimutho, Debottam Sinha, Jessie Jeffery, et al.
Cancer Discovery|January 21, 2016
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer ImmunotherapyStephen J Blake, Kimberley Stannard, Jing Liu, et al.
Cancer Immunology Research|March 22, 2019
CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor FunctionDeepak Mittal, Ailin Lepletier, Jason Madore, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancer Immunology Research|October 27, 2017
Interleukin-12 from CD103<sup>+</sup> Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of MetastasisDeepak Mittal, Dipti Vijayan, Eva M Putz, et al.
Touchreviews in Endocrinology|December 4, 2023
Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case ReportHiya Boro, Harish Sharma, Deepak Mittal, et al.
Touchreviews in Endocrinology|May 30, 2024
Erratum to Correct Informed Patient Consent StatementHiya Boro, Harish Sharma, Deepak Mittal, et al.
Cancer Research|September 1, 2017
CD73 Promotes Resistance to HER2/ErbB2 Antibody TherapyMartin Turcotte, David Allard, Deepak Mittal, et al.
Immunology and Cell Biology|September 18, 2018
The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cellsAilin Lepletier, Viviana P Lutzky, Deepak Mittal, et al.
Oncoimmunology|June 15, 2018
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisHeidi Harjunpää, Stephen J Blake, Elizabeth Ahern, et al.
Frontiers in Immunology|April 5, 2018
Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt SignalingJessica C Kling, Margaret A Jordan, Lauren A Pitt, et al.
EMBO Molecular Medicine|August 16, 2018
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerMurugan Kalimutho, Debottam Sinha, Jessie Jeffery, et al.
Cancer Discovery|January 21, 2016
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer ImmunotherapyStephen J Blake, Kimberley Stannard, Jing Liu, et al.
Cancer Immunology Research|March 22, 2019
CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor FunctionDeepak Mittal, Ailin Lepletier, Jason Madore, et al.
Pageof 7